References
- Grüneberg R. N. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection. J. Antimicrob. Chemother. 1975; 1: 3051. Grüneberg R. N. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection. J. Antimicrob. Chemother. 1975; 1: 305
- Grüneberg R. N. The microbiological rationale for the combination of sulphon-amides with trimethoprim. J. Antimicrob. Chemother. 1979; 5(Suppl. B)272. Grüneberg R. N. The microbiological rationale for the combination of sulphon-amides with trimethoprim. J. Antimicrob. Chemother. 1979; 5(Suppl. B)27
- Grüneberg R. N., Emmerson A. M. Prevention of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim. J. Antimicrob. Chemother. 1980; 6: 3493. Grüneberg R. N., Emmerson A. M. Prevention of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim. J. Antimicrob. Chemother. 1980; 6: 349
- Grüneberg R. N., Emmerson A. M. Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin. J. Antimicrob. Chemother. 1980; 6: 5624. Grüneberg R. N., Emmerson A. M. Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin. J. Antimicrob. Chemother. 1980; 6: 562
- Grüneberg R. N., Emmerson A. M. Prevention of emergence of bacterial resistance: no advantage in combining rifampicin and tetracycline over use of tetracycline alone. Chemotherapy 1981; 27: 1885. Grüneberg R. N., Emmerson A. M. Prevention of emergence of bacterial resistance: no advantage in combining rifampicin and tetracycline over use of tetracycline alone. Chemotherapy 1981; 27: 188
- Reeves D. S., Broughall J. M., Bywater M. J., Holt H. A. Pharmacokinetics of the combination sulfamoxole/trimethoprim (Co-trifamole). Sulfamoxole/Trimethoprim. R. Soc. Med. Int. Cong. Symp. Series No. 15, Academic Press, London 1979; 816. Reeves D. S., Broughall J. M., Bywater M. J., Holt H. A. Pharmacokinetics of the combination sulfamoxole/trimethoprim (Co-trifamole). Sulfamoxole/Trimethoprim. R. Soc. Med. Int. Cong. Symp. Series No. 15, Academic Press, London 1979; 81
- Reeves D. S., Bywater M. J., Holt H. A. The in vitro activity of sulfamoxole/trimethoprim (Co-trifamole). Sulfamoxole/Trimethoprim. R. Soc. Med. Int. Cong. Symp. Series No. 15, Academic Press, London 1979; 37. Reeves D. S., Bywater M. J., Holt H. A. The in vitro activity of sulfamoxole/trimethoprim (Co-trifamole). Sulfamoxole/Trimethoprim. R. Soc. Med. Int. Cong. Symp. Series No. 15, Academic Press, London 1979; 3
- Sourander L., Saarimaa H., Arvilommi H. Treatment of sulphonamide-resistant urinary infections with a combination of sulphonamide and trimethoprim. Acta Med. Scand. 1972; 191: 18. Sourander L., Saarimaa H., Arvilommi H. Treatment of sulphonamide-resistant urinary infections with a combination of sulphonamide and trimethoprim. Acta Med. Scand. 1972; 191: 1